Maternal death · women during pregnancy
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Maternal death · women during pregnancy
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
All‐cause mortality (outcome collected through first event: death, hospital discharge, hospital transfer, or 120 days after birth) · preterm infants with or at risk of respiratory distress syndrome
Inositol supplementation IV initially followed by enteral… showed no clear difference in all‐cause mortality (outcome collected through first event: death,… compared with placebo (moderate certainty).
1 finding from 1 review
Intervention not reported
Mortality All‐cause death · Pregnant women (parity 0‐1)
It is very uncertain whether the intervention changes mortality All‐cause death (very low certainty).
1 finding from 1 review
Intervention not reported
Mortality All‐cause death · Pregnant women (parity 2+)
It is very uncertain whether the intervention changes mortality All‐cause death (very low certainty).
1 finding from 1 review
Intervention not reported
Mortality All‐cause death · Pregnant women (all parities)
The intervention showed no clear difference in mortality All‐cause death (low certainty).
1 finding from 1 review
Intervention not reported
Mortality All‐cause death · Pregnant women (parity 0‐1)
It is very uncertain whether the intervention changes mortality All‐cause death (very low certainty).
1 finding from 1 review
All‐cause mortality (number of deaths during trial) · preschool and school‐age children
1 finding from 1 review
All‐cause mortality – deaths · adults with or without existing CVD
High showed no clear difference in all‐cause mortality – deaths compared with low long‐chain omega‐3 fats (high certainty).
1 finding from 1 review
All‐cause mortality – deaths · adults with or without existing CVD
High showed no clear difference in all‐cause mortality – deaths compared with low alpha‐linolenic acid omega‐3 fats (moderate certainty).
1 finding from 1 review
All‐cause mortality during initial hospitalization ‐ not reported · infants at risk of hypoglycaemia or hyperglycaemia
It is very uncertain whether summary of findings table ‐ Continuous glucose monitoring (CGM) changes death during initial hospitalization (all‐cause mortality) compared with intermittent modalities (very low certainty).
1 finding from 1 review
Time to death from any cause (here: overall mortality at 12‐month · advanced hormone‐sensitive prostate cancer
Early probably leads to lower time to death of any cause (here: all‐cause mortality at 5 years) compared with deferred AST (moderate certainty).
1 finding from 1 review
All‐cause mortality (within 30‐days after surgery: any reported death) · adults undergoing non‐cardiac surgery
1 finding from 1 review
All‐cause mortality (within 30‐days after surgery: any reported death) · adults undergoing cardiac surgery
Alpha‐2 adrenergic agonists showed no clear difference in all‐cause mortality (within 30‐days after surgery: any reported death) compared with control (moderate certainty).
1 finding from 1 review
Late neonatal mortality · Neonates and caregivers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Late neonatal mortality · Neonates and caregivers
It is very uncertain whether alcohol‐based handrub changes all‐cause mortality from the 8th to 28th day of life (late neonatal… compared with usual care (very low certainty).
1 finding from 1 review
Early neonatal mortality · Neonates and caregivers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Early neonatal mortality · Neonates and caregivers
It is very uncertain whether alcohol‐based handrub changes all‐cause mortality within the first seven days of life (early… compared with usual care (very low certainty).
1 finding from 1 review